Clinical Trial Update: Dasatinib in Treating Patients With Locally Advanced or Metastatic Mucosal Melanoma, Acral Melanoma, or Vulvovaginal Melanoma That Cannot Be Removed By Surgery [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating dasatinib for locally advanced or metastatic mucosal, acral, or vulvovaginal melanomas that are unresectable by surgery; study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• DASATINIB (Dasatinib)

Snippet

Sponsor: Eastern Cooperative Oncology Group | Conditions: Melanoma (Skin) | Phase 2 | Status: COMPLETED | Results posted: 2020-02-24